Safety assessment of PureSorb-Q™40 in healthy subjects and serum coenzyme Q10 level in excessive dosing

Journal of Nutritional Science and Vitaminology

Volumn 53, Issue 3, 2007, Pages 198-206

  Nukui, Kazuki ^a   Matsuoka, Yuki ^a   Yamagishi, Toshihiko ^a   Miyawaki, Hiromi ^b   Sato, Kiyoshi ^a  

^a NISSHIN SEIFUN GROUP INC   (Japan)

^b Miyawaki Orthopedic Clinic   (Japan)

Author keywords

Clinical trial; Coenzyme Q10; PureSorb Q 40; Toxicity; Water soluble

Indexed keywords

UBIDECARENONE;

ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG DOSAGE FORM; DRUG DOSAGE FORM COMPARISON; DRUG SAFETY; HUMAN; LIPID SOLUBILITY; NORMAL HUMAN; POSTPRANDIAL STATE; TABLET FORMULATION; URINALYSIS;

ADULT; BLOOD CELL COUNT; BLOOD PRESSURE; COENZYMES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG TOXICITY; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HEMATOCRIT; HEMOGLOBINS; HUMANS; MALE; PHYSICAL EXAMINATION; REFERENCE VALUES; TABLETS; UBIQUINONE;

RATTUS;

EID: 34547678502     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.53.198     Document Type: Article

References (13)

1. Kishi T. 2001. The role of coenzyme Q in the mitochondrial respiratory chain. Vitamins 75: 263-271.
2. Lenaz GA, Baracca C, Bovina M, Cavazzoni M, D'Aurelio S, Di Bernardo R, Fato G, Formiggini ML, Genova AM, Ghelli MM, Pich F, Pallotti GP, Castelli, Ventura B. 2000. Mitochondrial bioenergetics in health and disease. Recent Res Develop Bioenerg 1: 63-101.
3. Shunk CH, Linn BO, Wong EL, Wittreigh PE, Robinson PE, Folkers K. 1958. Coenzyme Q II. J Am Chem Soc 80: 47523.
4. 10) in healthy subjects: A double-blind, randomized, Placebo-controlled trial. Regul Toxicol Pharmacol 44: 212-218.
5. 10. J Nutr Sci Vitaminol 51: 45-47.
6. 10 and its (2Z)-isomer in rat: Single and four-week repeated dose toxicity studies. J Nutr Sci Vitaminol 52: 9-20.
7. Weber C, Bysted A, Holmer G. 1997. Coenzyme Q10 in the diet-daily intake and relative bioavailability. Molec Aspects Med 18S: s251-s254.
8. Nukui K, Koile T, Yamagishi T, Ihota H, Nagase T, Kimura H, Sato K. 2007. A 91-day repeated dose oral toxicity study of PureSorb-Q™40 in rats. J Nutr Sci Vitaminol 53: in press.
9. 10 in rats and humans after single oral intake. J Nutr Sci Vitaminol 53: 187-190.
10. Sekine K, Ota N, Nishii M, Uetake T, Shimadzu M. 2005. Estimation of plasma and saliva levels of coenzyme Q10 and influence of oral supplementation. BioFactors 25: 205-211.
11. 10 therapy in Parkinson disease could be symptomatic. Arch Neurol 60: 1170-1173.
12. Langsjoen H, Langsjoen P, Willis R. 1994. Usefulness of coenzyme Q10 in clinical cardiology: A long-term study. Molec Aspects Med 15S: s165-s175.
13. Kitaura T, Tsukiai S, Kumagai M, Arai S, Miyake K, Kimura M, Fukuchi H. 1988. Effect of chenodeoxycholic acid and flopropione on plasma ubidecarenone concentration following oral administration. Yakuzai-gaku 48: 132-138.